Literature DB >> 12423223

Distribution of enrofloxacin in intestinal tissue and contents of healthy pigs after oral and intramuscular administrations.

C Wiuff1, J Lykkesfeldt, F M Aarestrup, O Svendsen.   

Abstract

The concentration of enrofloxacin in plasma, intestinal tissue, lymph nodes and intestinal contents was investigated in healthy pigs after oral (p.o.) and intramuscular (i.m.) administration of a single dose of 2.5 mg/kg bw. Tissue and content samples were collected from jejunum, ileum, caecum and colon from pigs killed at 2, 3 and 6 h after dosing. Intramuscular administration resulted in significantly higher concentrations in plasma, intestinal tissue and lymph nodes at 2 h but not at 3 or 6 h compared with p.o. administration. The absorption and distribution phase was longer after oral administration, and maximum concentrations in tissue and plasma were determined later than after i.m. administration. No difference between route of administration was observed in the intestinal content. Enrofloxacin concentrations in faeces during a 5-day dosing regimen with i.m. and p.o. administration were determined by both HPLC and bio-assay. Higher concentrations were found after i.m. administration during the first day, but the difference was not significant after 2 days. The biologically active concentrations determined by bio-assay constituted 48-75% of the total concentrations determined by HPLC. On the basis of these results it was concluded that in order to ensure an immediate high concentration of enrofloxacin, and thereby avoid an initial selection for resistant mutants, the intramuscular route seems to be preferable to the oral route.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12423223     DOI: 10.1046/j.1365-2885.2002.00430.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  17 in total

1.  Tissue distribution of enrofloxacin in African clawed frogs (Xenopus laevis) after intramuscular and subcutaneous administration.

Authors:  Stephen Felt; Mark G Papich; Antwain Howard; Tyler Long; Gabriel McKeon; Stéphanie Torreilles; Sherril Green
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-03       Impact factor: 1.232

2.  Efficacy of enrofloxacin in a mouse model of sepsis.

Authors:  Andrea R Slate; Sheila Bandyopadhyay; Kevin P Francis; Mark G Papich; Brian Karolewski; Eldad A Hod; Kevin A Prestia
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-07       Impact factor: 1.232

3.  Effect of on-farm use of antimicrobial drugs on resistance in fecal Escherichia coli of preweaned dairy calves.

Authors:  R V Pereira; J D Siler; J C Ng; M A Davis; Y T Grohn; L D Warnick
Journal:  J Dairy Sci       Date:  2014-10-11       Impact factor: 4.034

4.  Effect of administration route and dose escalation on plasma and intestinal concentrations of enrofloxacin and ciprofloxacin in broiler chickens.

Authors:  Mathias Devreese; Gunther Antonissen; Siegrid De Baere; Patrick De Backer; Siska Croubels
Journal:  BMC Vet Res       Date:  2014-12-02       Impact factor: 2.741

5.  Pharmacokinetic and Pharmacodynamic Integration and Modeling of Enrofloxacin in Swine for Escherichia coli.

Authors:  Jianyi Wang; Haihong Hao; Lingli Huang; Zhenli Liu; Dongmei Chen; Zonghui Yuan
Journal:  Front Microbiol       Date:  2016-02-02       Impact factor: 5.640

6.  Effects of intramuscularly administered enrofloxacin on the susceptibility of commensal intestinal Escherichia coli in pigs (sus scrofa domestica).

Authors:  Antje Römer; Gesine Scherz; Saskia Reupke; Jessica Meißner; Jürgen Wallmann; Manfred Kietzmann; Heike Kaspar
Journal:  BMC Vet Res       Date:  2017-12-04       Impact factor: 2.741

7.  Clinical Efficacy and Residue Depletion of 10% Enrofloxacin Enteric-Coated Granules in Pigs.

Authors:  Zhixin Lei; Qianying Liu; Bing Yang; Jincheng Xiong; Kun Li; Saeed Ahmed; Liping Hong; Pin Chen; Qigai He; Jiyue Cao
Journal:  Front Pharmacol       Date:  2017-05-23       Impact factor: 5.810

8.  Distribution of Flumequine in Intestinal Contents and Colon Tissue in Pigs after Its Therapeutic Use in the Drinking Water.

Authors:  Jose M Rodríguez; M Jose Diez; Matilde Sierra; Juan J Garcia; Nelida Fernandez; Raquel Diez; Ana M Sahagun
Journal:  Animals (Basel)       Date:  2021-05-23       Impact factor: 2.752

9.  Mathematical modeling of bacterial kinetics to predict the impact of antibiotic colonic exposure and treatment duration on the amount of resistant enterobacteria excreted.

Authors:  Thu Thuy Nguyen; Jeremie Guedj; Elisabeth Chachaty; Jean de Gunzburg; Antoine Andremont; France Mentré
Journal:  PLoS Comput Biol       Date:  2014-09-11       Impact factor: 4.475

10.  Pharmacokinetic-Pharmacodynamic Modeling of Enrofloxacin Against Escherichia coli in Broilers.

Authors:  KaNa Sang; HaiHong Hao; LingLi Huang; Xu Wang; ZongHui Yuan
Journal:  Front Vet Sci       Date:  2016-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.